跳至主要内容
临床试验/NCT00773058
NCT00773058Unknown4 期

Effect of Treatment With Stress-Doses Glucocorticoid on Mortality in Patients With ARDS and Relative Adrenal Insufficiency

Southeast University, China0 个研究点目标入组 100 人开始时间: 2008年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
主要终点
Evidence of clinically definite ARDS confirmed by AECC criteria in 1994

研究概览

简要总结

The purpose of this study is to see if stress doses of hydrocortisone improve early outcome in patients who are in early stage of ARDS and with relative adrenal insufficiency.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • within the first 3 days of onset of clinically definite ARDS confirmed by AECC criteria in 1994
  • 18 to 85 year old

排除标准

  • pregnancy or lactation
  • tumor or other immunologic disease
  • immunosuppressive drug used
  • bone marrow or lung transplantation
  • primary or secondary disease of adrenal gland
  • hormone used within 3 months
  • refusing conventional therapy
  • be in other clinical tests within 30 days

研究组 & 干预措施

glucocorticoid+RAI

Active Comparator

stress-dose glucocorticoid treatment, compared to placebo group and ACTH test hints RAI

干预措施: hydrocortisone (Drug)

placebo + RAI

Placebo Comparator

no glucocorticoid But ATCH test hints RAI

干预措施: placebo (Drug)

glucocorticoid

Active Comparator

stress-dose glucocorticoid treatment, compared to placebo group and ACTH test does not hint RAI

干预措施: hydrocortisone (Drug)

placebo

Placebo Comparator

no glucocorticoid But ATCH test does not hint RAI

干预措施: placebo (Drug)

结局指标

主要结局

Evidence of clinically definite ARDS confirmed by AECC criteria in 1994

时间窗: within the first 3 days after surgery onset of ARDS

次要结局

未报告次要终点

研究者

发起方
Southeast University, China
申办方类型
Other

相似试验